about
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based studyDeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthmaCausal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.Risk for asthma in offspring of asthmatic mothers versus fathers: a meta-analysis.Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy.Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals.Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.Susceptibility to chronic mucus hypersecretion, a genome wide association study.Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases.Stiffness and thickness of fascia do not explain chronic exertional compartment syndromeProtection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/IIHuman apolipoprotein E genotypes differentially modify house dust mite-induced airway disease in micePulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility.Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals.Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood typeGenetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases.Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.Risk Factors for Chronic Cough Among 14,669 Individuals From the General Population.Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis.Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Tobacco smoking and aortic aneurysm: two population-based studies.C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.Correction: Susceptibility to chronic mucus hypersecretion, a genome wide association study.Characteristics of undertreatment in COPD in the general population.β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach.Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.Pharmacogenetics of COPD: a role for the β2-adrenergic receptor gene?Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity.Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals.Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study.Influence of the factor V Leiden mutation on infectious disease susceptibility and outcome: a population-based study.Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease.Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals.Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.β2 -adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals.Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting.
P50
Q24814073-A15FA417-858A-4688-A055-00176F20639CQ28275756-88B22BD2-F3E7-4F50-9EC7-0B23D7A050A7Q31129874-9F4B1AE3-CEEF-4244-9EE6-729423363B8CQ33559871-A5656F52-4232-42D0-A570-2CB133D29F18Q33851524-B442C5AA-8EA0-4192-8A6C-AEEE6B2D4926Q34190942-69D4ADB4-9453-4A0B-8D73-A9998518C18AQ34826231-A8B7BCB8-A326-456B-837F-E98109C3082DQ35143045-D9CB23CB-2864-4729-97B0-EBC52321DACAQ35482466-8270D2AF-B7B5-4844-8C87-6E0E9BF68DFFQ35533956-5C613BB2-486D-4659-8BF5-2503D0FDFEBBQ35649450-C4D29D7F-23BD-4092-9B14-4E52740FA0C5Q35950145-8788805F-BD41-499F-B840-4BDBBFFE10C2Q36330693-375D78E7-75A2-4CC1-973E-F49DA367E43AQ36444684-5642773B-BA6C-42D6-8E73-7F28C6BB003EQ36698661-7B20CB91-E438-4EB5-9EE4-F81C84EBA05FQ36902682-2E6272FE-1353-4AF1-B641-781F3EA01D52Q36960786-9274628A-845A-46E2-88D8-EC59D65E9D75Q38720478-F8717CB2-B088-43D6-81D3-84C1E377D01DQ38871123-51E68E7C-2AE7-4A86-9ADD-F74A6C4DC759Q39307440-E14C8403-4312-4A1B-A935-602295C1456BQ39597955-25469CF6-FB49-4535-A83B-6EF0316FC58CQ40277494-46865754-D559-4E17-AA53-E39E2CC6273DQ42881151-E762E782-7276-4E94-801F-5BEC3AF37383Q43523900-6FDB5BDA-1E0A-40AA-89AE-18B2DEBE5265Q44008986-163C6CA1-EB78-475B-8ABB-BB4AA828B59EQ44077968-39F382DF-99A1-4CAD-9321-ADE5DFAF0952Q44687503-36A0420E-2B21-4F74-87BA-F4E97847724EQ44778916-A7304FFD-66D0-4552-A911-6D5C5434D100Q44827872-60F7FEF8-5E90-4A7D-A541-60BBE3C5AE42Q46021380-21E12C4F-CD0D-40AA-9B2C-2CFF6FF37634Q46091192-43CD3690-AAE1-419A-91D3-5A95A920D501Q47220914-DC89C7EB-561A-4221-AE7B-A9F552395B75Q47665346-9BA9864A-96A4-4E9A-B4A0-A4DF800AC4F2Q47707831-C4639BA2-6001-4F85-A410-B836EFC326D6Q48398170-C02B1FD4-B1FD-4F8A-8924-3CA2CD03A674Q48611059-CC1E27E0-E6F2-432D-AC35-055C302B525CQ50554528-DAE53000-4AEE-4BE0-9FDF-87BB62934E5CQ50691504-4B65C311-5E3C-404F-B754-4851B7570D86Q51419724-90A59998-EA64-4023-ABBF-34ACC08AC91FQ53024721-66CFF8D1-D425-4898-851F-386B9C10788D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Morten Dahl
@ast
Morten Dahl
@en
Morten Dahl
@es
Morten Dahl
@nl
Morten Dahl
@sl
type
label
Morten Dahl
@ast
Morten Dahl
@en
Morten Dahl
@es
Morten Dahl
@nl
Morten Dahl
@sl
prefLabel
Morten Dahl
@ast
Morten Dahl
@en
Morten Dahl
@es
Morten Dahl
@nl
Morten Dahl
@sl
P1053
F-4219-2014
P106
P21
P31
P3829
P496
0000-0002-6686-312X